#Thyroid ABLATION Treatment in India
Text
Thyroid Nodule Treatment in Mumbai : Leading the Way with Minimally Invasive Techniques
INTRODUCTION
Dr. Gaurav Gangwani: Leading non-surgical expert in thyroid nodule treatment in mumbai,India, pioneering safer, quicker alternatives.
Dr. Gaurav Gangwani: A Beacon of Innovation in Thyroid Care
A pioneer in the field of interventional radiology, especially when it comes to treating thyroid nodules, is Dr. Gaurav Gangwani. Mumbai's approach to thyroid care has changed as a result of his proficiency in cutting-edge procedures like microwave ablation, radiofrequency ablation (RFA), and thyroid nodule ablation. Patients are guaranteed the best care possible with the least amount of suffering according to Dr. Gangwani's patient-centric approach and dedication to minimally invasive treatment.
The Transition to Non-Surgical Thyroid Nodule Treatment
Thyroid nodules, often discovered incidentally during routine check-ups, can cause anxiety among patients. While most thyroid nodules are benign, the traditional approach to managing symptomatic or suspicious nodules has been surgical removal. However, the landscape of thyroid nodule treatment in Mumbai is changing, with a significant shift towards non-surgical options that promise effective outcomes without the risks and recovery time associated with conventional surgery.
Thyroid Nodule Ablation: A Game-Changer
Thyroid nodule ablation stands out as a revolutionary technique in treating thyroid nodules without surgery. This procedure involves the use of heat generated by microwave energy or radiofrequency to destroy nodule tissue, leaving the surrounding thyroid gland intact. The benefits of this approach include minimal scarring, preservation of thyroid function, and a quicker return to daily activities.
Microwave Ablation and RFA: Leading Techniques in Thyroid Care
Microwave ablation and Radiofrequency Ablation (RFA) are leading the charge in non-surgical thyroid nodule treatment. These procedures offer a targeted approach to nodule destruction, with precise control over the ablation process. Dr. Gangwani’s expertise in these techniques has made him a sought-after specialist for patients seeking alternative treatments to thyroid surgery in Mumbai.
The Role of Ablation in Treating Goiter
Ablation techniques are useful not only for treating individual thyroid nodules but also for the treatment of goiter, a condition in which the thyroid gland enlarges. Further demonstrating the adaptability of these cutting-edge therapies, ablation provides a less invasive way to shrink the goiter and relieve symptoms including breathing problems and neck pain.
The Future of Thyroid Nodule Treatment in Mumbai, India
The future of thyroid nodule treatment in Mumbai looks promising, with continued advancements in minimally invasive techniques and the growing expertise of specialists like Dr. Gaurav Gangwani. As awareness of these treatment options increases, more patients are likely to benefit from the less invasive, highly effective approaches to managing thyroid conditions.
In conclusion, Mumbai stands at the forefront of modern thyroid care, offering advanced, minimally invasive treatments for thyroid nodules. With the expertise of interventional radiologists like Dr. Gaurav Gangwani, patients can access the latest in thyroid nodule ablation, microwave ablation, and RFA, ensuring effective treatment with minimal discomfort and downtime. As the city continues to embrace these innovative techniques, the future of thyroid care in Mumbai remains bright, offering new hope and improved outcomes for patients facing thyroid health challenges.
0 notes
Text
Dr. Gaurav Gangwani, An interventional radiologist in Mumbai, is changing healthcare with minimally invasive interventions.
INTRODUCTION
Doctor Gaurav Gangwani, an interventional radiologist in Mumbai who is dedicated to offering cutting-edge care without the need for surgery, is in charge of this life-changing adventure. One minimally invasive operation at a time, Dr. Gangwani, an Interventional Radiologist with over ten years of experience and a genuine commitment to patient-centered care, is redefining healthcare in Mumbai.
Who is Dr. Gaurav Gangwani?
Dr. Gaurav Gangwani is not your average physician. As an Interventional Radiologist, his specialty lies in performing minimally invasive interventions that can address complex medical conditions with precision and effectiveness, all without the need for surgery. Trained in some of the country's premier institutes and enriched by international experiences in New Zealand, Japan, and America, Dr. Gangwani brings a wealth of knowledge and expertise to his practice in Mumbai, India.
The Difference with Minimally Invasive Interventions
What sets Dr. Gangwani apart is his commitment to offering minimally invasive interventions that prioritize patient comfort and safety. Unlike traditional surgical procedures, which often involve large incisions and lengthy recovery times, Dr. Gangwani's interventions are performed through small punctures in the wrist, thigh, or body, under local anesthesia, and on a daycare basis. This means patients can undergo treatment and return home on the same day, with minimal downtime and immediate recovery.
Why Choose Dr. Gaurav Gangwani?
The answer lies in Dr. Gangwani's approach to patient care. With a focus on building valuable relationships with his patients, Dr. Gangwani takes the time to understand their concerns, explain treatment options, and empower them with the knowledge to make informed decisions. His transparent counseling ensures that patients are fully aware of their choices, allowing them to choose or reject treatment decisions wisely.
Services Offered
Dr. Gaurav Gangwani offers a wide range of minimally invasive interventions to address various medical conditions. These include but are not limited to:
Vascular Interventions: Treatment of vascular conditions such as peripheral artery disease using minimally invasive techniques like angioplasty and stenting.
Pain Management: Interventional procedures to alleviate chronic pain conditions, including nerve blocks, epidural injections, and radiofrequency ablation.
Thyroid Nodule Ablation: Innovative techniques like radiofrequency ablation and microwave ablation to treat thyroid nodules without surgery.
Diabatic Foot Treatment: Diabetes foot treatment in India has significantly improved, especially with the use of angioplasty, thanks to technological breakthroughs in medicine and the knowledge of medical experts such as renowned Interventional Radiologist Dr. Gaurav Gangwani.
Building a Better Future for Healthcare in Mumbai
With Dr. Gaurav Gangwani leading the way, the future of healthcare in Mumbai looks brighter than ever. By embracing minimally invasive interventions, patients can benefit from advanced treatments that offer effective results with minimal risk and downtime. Dr. Gangwani's dedication to patient-centered care and his commitment to excellence ensure that every patient receives the highest quality of care possible.
Conclusion
In a city known for its hustle and bustle, Dr. Gaurav Gangwani stands as a beacon of hope for those seeking advanced healthcare solutions. Through his expertise in minimally invasive interventions and his unwavering dedication to patient care, Dr. Gangwani is transforming the lives of patients in Mumbai and beyond. With him at the helm, the future of healthcare looks brighter than ever, promising a world where advanced treatments offer hope and healing to all.
#healthcare#Interventional Radiologist#Diabatic foot treatment#Varicocele treatment#Thyroid Nodule Treatment
0 notes
Text
Turbinoplasty Surgery
Turbinoplasty is a surgical procedure aimed at addressing nasal congestion and breathing difficulties caused by enlarged turbinates. The turbinates are bony structures covered in soft tissue located inside the nose, responsible for filtering, warming, and humidifying the air we breathe. When the turbinates become swollen due to allergies, chronic sinusitis, or other nasal conditions, it can lead to nasal obstruction and reduced airflow. Turbinoplasty involves the reduction or repositioning of the turbinates to improve nasal airflow and alleviate breathing problems.
MedFirst ENT Centre, located in Delhi, India, offers top-quality turbinoplasty surgery performed by highly skilled ENT surgeon and their professional medical team.
Turbinoplasty - Benefits and Risks
Benefits of Turbinoplasty Surgery: Improved Breathing: Turbinoplasty can significantly enhance nasal airflow, leading to better breathing and reduced nasal congestion. Relief from Nasal Obstruction: Patients may experience relief from chronic nasal obstruction, leading to improved sleep quality and overall comfort. Better Quality of Life: Improved nasal function can enhance the quality of life, allowing patients to engage in daily activities more comfortably. Enhanced Sinus Health: Turbinoplasty may complement the treatment of chronic sinusitis, as improved nasal airflow can aid in sinus drainage.
Risks and Potential Complications: Bleeding: Some patients may experience minor bleeding after the surgery, which is usually temporary and manageable. Infection: As with any surgery, there is a small risk of infection, but proper preoperative and postoperative care can help minimize this risk. Scarring: In rare cases, the surgery may lead to scarring or adhesions inside the nose, but this can be addressed with appropriate medical care. Nasal Dryness: Some patients may experience temporary nasal dryness following the procedure, which can be alleviated with nasal moisturizers.
The Procedure Process
Before the surgery, patients undergo a thorough examination by an ENT specialist to determine the extent of nasal obstruction and the suitability of turbinoplasty. The procedure can be performed under local or general anaesthesia, depending on the patient’s preference and the surgeon’s recommendation.
Anaesthesia: The surgeon administers anaesthesia to ensure the patient’s comfort during the procedure.
Turbinoplasty Technique: The surgeon may employ various techniques to reduce or reposition the turbinates, such as radiofrequency ablation, submucosal resection, or partial turbinectomy. Special instruments like Microdebrider, Coblation, or Laser may also be used.
Recovery: After the procedure, patients are monitored in a recovery area to ensure a smooth awakening from anaesthesia.
Post-operative Care: Patients receive instructions on caring for the nose, managing pain, and avoiding certain activities during the initial recovery phase. Recovery takes about one to two weeks.
Before and After Care for Turbinoplasty Surgery
Before Turbinoplasty Surgery: Medical Evaluation: Patients will undergo a comprehensive medical evaluation to assess their overall health and suitability for the surgery.
Medication Review: The surgeon will review the patient’s current medications and may advise temporary adjustments to certain drugs before the procedure. Blood thinners are sometimes stopped a couple of days before the surgery. BP and Thyroid medicines should continue.
After Turbinoplasty Surgery: Nasal Hygiene: Patients will be instructed on proper nasal hygiene, including saline rinses, to promote healing and reduce the risk of infection.
Activity Restrictions: Patients may need to avoid strenuous activities and heavy lifting during the initial recovery period.
Follow-up Appointments: Regular follow-up appointments will be scheduled to monitor the healing process and assess the surgical outcomes.
Recovery Timeline:
The recovery timeline can vary from patient to patient, but most individuals can expect to resume normal daily activities within a few days to a week after the surgery. Full recovery and optimal results may take several weeks.
Cost and Insurance Information-Turbinoplasty
The cost of turbinoplasty surgery can depend on factors such as the geographical location, the complexity of the procedure, and individual patient needs including their personal preference for a technique. Patients are advised to check with their health insurance provider to determine coverage and associated costs.
Why Choose Comprehensive ENT Centre:
At MedFirst, we take pride in offering exceptional patient care and cutting-edge treatments. Here’s why you should choose us:
Advance Technology and Mechanism Being Used Here:
Our facility is equipped with state-of-the-art technology and modern surgical tools to ensure the highest level of precision and safety during turbinoplasty surgery. We utilize advanced techniques such as radiofrequency ablation/Microdebrider/ Coblation and endoscopic procedures for optimal results.
Qualifications of the Surgeon and Medical Team:
Our highly skilled and experienced ENT surgeons are experts in performing turbinoplasty surgery. Dr. (Maj.) Rajesh Kumar Bhardwaj, most experienced ENT surgeon, has over 30 years of surgical experience, including a distinguished service in the Indian army. Our medical team is committed to providing compassionate and individualized care to each patient.
Choosing MedFirst, means entrusting your health to a team of dedicated professionals who prioritize patient well-being and ensure the best possible surgical outcomes.
youtube
#Turbinoplasty #ENTProcedure #NasalHealth #BreathingWell #TurbinoplastySurgery #ENTCare #SinusRelief #NasalAirflow #HealthcareExplained #DrRajeshBhardwaj #ENTSpecialist #ImprovedBreathing #SurgicalInnovation #NasalWellness #MedicalExpertise #HealthEducation #ENTInsights #BreathingBetter #TurbinoplastyRecovery #PatientExperience
0 notes
Text
Benign and Malignant Soft Tissue Tumors Treatment Market Analysis and Forecast to 2029
Global Benign and Malignant Soft Tissue Tumors Treatment Market, By Types Benign Schwannoma, Desmoid Tumor, Lipoblastoma, Lipoma, Solitary, Uterine Leiomyoma, Clear Cell Sarcoma, Dermatofibrosarcoma Protuberans, Ewing Sarcoma, Extraskeletal Myxoid Chondrosarcoma, Liposarcoma, Myxoid, Liposarcoma, Well Differentiated, Alveolar Rhabdomyosarcoma, Synovial Sarcoma, Others), Treatment (Medical Therapy, Surgical Therapy, Postoperative Therapy, Long Term Monitoring, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
The consistent Benign and Malignant Soft Tissue Tumors Treatment market report analyzes many points that help businesses to solve the toughest questions in less time. The major topics of this business report are global growth trends, market share by manufacturers, market size by type, market size by application, production by region, consumption by region, company profiles, market forecast, value chain and sales channels analysis, opportunities & challenges, threat and affecting factors. The report gives market definition in the form of market driving factors and market restraints which helps estimating the demand of particular product depending on several aspects. Benign and Malignant Soft Tissue Tumors Treatment market survey report studies the global market status and forecast, categorizes the global market size, market value & market volume by key players, type, application, and region.
Key Players
Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
Novartis AG (Switzerland)
Bayer AG (Germany)
Lilly (U.S.)
Merck & Co., Inc. (U.S.)
Sun Pharmaceutical Industries Ltd. (India)
Browse More Info @ https://www.databridgemarketresearch.com/reports/global-benign-and-malignant-soft-tissue-tumors-treatment-market
One of the principal objectives of a high-ranking Benign and Malignant Soft Tissue Tumors Treatment industry report is to analyze and study the global sales, value, status, and forecast. The market report also analyzes the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. The report assists to define, describe and forecast the market by type, application and region. It estimates the region that is foretold to create the most number of opportunities in the global Benign and Malignant Soft Tissue Tumors Treatment market. This market research report comprises of estimations of CAGR values which are quite significant and aids businesses to decide upon the investment value over the time period. An insightful Benign and Malignant Soft Tissue Tumors Treatment market report assists clients to stay ahead of the time and competition.
Key questions answered in the report:
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
Report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Benign and Malignant Soft Tissue Tumors Treatment Market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Table Of Content
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Market
Part 04: Global Market Sizing
Part 05: Global Market Segmentation By Product
Part 06: Five Forces Analysis
More Reports:
Middle East and Africa Thyroid Ablation Devices Market
Europe Thyroid Ablation Devices Market
U.S. Dermatology Drugs Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
0 notes
Text
Bone Metastasis Market Analysis in Developed Countries
Bone metastasis market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 26.99 billion by 2027 growing with the CAGR of 8.01% in the above-mentioned forecast period. The growing prevalence of cancer diseases such as breast cancer and prostate cancer will help in driving the growth of the bone metastasis market.
Increasing healthcare expenditures and growing geriatric population will likely to accelerate the growth of the bone metastasis market in the forecast period of 2020-2027. On the other hand, growing technological advancements and new product development with clinical trial will further boost various opportunities that will lead to the growth of the bone metastasis market in the above mentioned forecast period.
Download full sample report of Bone metastasis market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bone-metastasis-market
Lack of healthcare services in low income countries and high cost treatment will likely to hamper the growth of the bone metastasis market in the above mentioned forecast period.
This bone metastasis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on bone metastasis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Bone Metastasis Market By Type (Osteolytic Bone Metastasis, Osteoblastic Bone Metastasis, Mixed Bone Metastasis, Others), Origin (Breast, Lung, Thyroid, Kidney, Prostate, Others), Diagnosis (Biopsy, Blood Test, Imaging, Others), Treatment (Drug Treatment, Osteoplasty, Orthopedic Fixation, Medical Therapies, Surgical Treatment, Medication, Others), End User (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
Global Bone Metastasis Market Scope and Market Size
Bone metastasis market is segmented on the basis of type, origin, diagnosis, treatment and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on type, the bone metastasis market is segmented into osteolytic bone metastasis, osteoblastic bone metastasis, mixed bone metastasis and others.
On the basis of origin, the bone metastasis market is segmented into breast, lung, thyroid, kidney, prostate and others.
Based on diagnosis, the bone metastasis market is segmented into biopsy, blood test, imaging and others
Based on treatment, the bone metastasis market is segmented into drug treatment, osteoplasty, orthopedic fixation, medical therapies, surgical treatment, medication and others. The drug treatment is further sub-segmented into pain relievers, bone building medications and targeted therapy agents. The medical therapies are further sub-segmented into chemotherapy, targeted therapy, hormone therapy, ablation therapy, external radiation therapy and immunotherapy. The ablation therapy is further sub- segmented into cryoablation and radiofrequency ablation. The medication is further sub-segmented into pain medications, bone building medications and others.
Bone Metastasis market has also been segmented based on the end user into hospitals, clinics, diagnostic centers, and ambulatory surgical centers.
Bone Metastasis Market Country Level Analysis
Bone metastasis market is analysed and market size insights and trends are provided by country, type, origin, diagnosis, treatment and end user as referenced above.
The countries covered in the bone metastasis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the bone metastasis market due to increased prevalence of cancer and increased investment in research, and developed which is further supported by the FDA approval and launch of various new drugs, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to growing awareness among people, increased prevalence of cancer, and FDA approval.
The country section of the bone metastasis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Bone Metastasis Market Share Analysis
Bone metastasis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to bone metastasis market.
The major players covered in the bone metastasis market report are Bayer AG, Merck & Co., Inc., Pfizer Inc., Novartis AG, Pharmalucence Inc., Koninklijke Philips N.V., GE Healthcare, Siemens, Amgen Inc, Catena Pharmaceuticals, Eli Lilly and Company, Pfizer Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Want any help speak to our analyst @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-bone-metastasis-market
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-bone-metastasis-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports @
Healthcare Human Resources (HR) Software Market
Preoperative Surgical Planning Software Market
0 notes
Text
Thyroid : types,symptoms and treatment
What is thyroid?
The thyroid is a small, butterfly shape having gland. It is located at the base area of neck part, below the Adam’s apple in the body.
Thyroid is a part of an intricate network of glands named the endocrine system. The endocrine system plays role in coordinating many of body’s activities. This thyroid gland produces hormones that can regulate the metabolism of body.
Hyperthyroidism takes place in the situation when the amount of thyroid production is too much.
Hypothyroidism take place when the thyroid gets reduced too little.
The common disease related to thyroid are:
Hashimoto’s disease, Graves’ disease, goiter, and thyroid nodules.
Goiter
Goiter means enlargement of the thyroid glands without any specific reason. It could be related with hypothyroidism, hyperthyroidism, or normally function of thyroid. Goiter can affect other parts of body as well.
Thyroid cancer
Thyroid cancer is mostly seen in adult women than men or young people.
There are different types of thyroid cancer, which depends upon the specific cell type within the thyroid that has turned into cancerous.
Most cases of thyroid cancer can have prognosis and higher rates of survival, when they are diagnosed in the early stages of disease.
Thyroid nodules
Nodules are the lumps or abnormal masses which are seen in the thyroid. Benign cysts, benign tumors or less commonly by cancers of the thyroid produce nodules. They are seen single or multiple. If they are too much large, they can cause symptoms related to compression of nearby structures in the body.
What are the treatments available for thyroid diseases?
Thyroid medications
Medications are given for replacing the missing thyroid hormones in hypothyroidism. Synthetic thyroid hormones are given in pill form by mouth. When patient is having hyperthyroidism, medications are be used to decrease production of thyroid hormone. The medicines also prevent its release from the gland. Increased heart rate can also be regulated using these medications.
Radioactive ablation can be performed if medicines doesn't work. In ablation doses of iodine are given. These doses are labelled with radioactivity which selectively destroys the thyroid tissue and cures the disease.
Thyroid surgery
To remove a large goiter or a hyper functioning nodule surgery is carried out. Surgery is needful in the case of thyroid cancer. If the thyroid gland is getting removed during the surgery, the individual might need to take synthetic thyroid hormone for lifetime.
Thyroid is a serious disease said by 3MEDS the best pharmacy store in India . Thyroid needs special attention. Thyroid needs must be taken care of. A few home remedies are not enough for thyroid. So it's necessary to consult a doctor for assistance and to cure this thyroid
0 notes
Text
Breast Cancer Treatment Guidelines & The Preventive Measures
Breast cancer, the most common invasive cancer in women that takes many lives every year. Isn’t it feels so sad and unfair?
Although death is inevitable, we don’t want to die with sickness. The good thing is that the advances in screening and Breast Cancer Treatment Guidelines have improved survival rates dramatically.
If you are unaware of the symptoms then it might be difficult to reduce the risk factors. Therefore, we, at Canwinn Foundation are going to share some important things along with Breast Cancer Treatment Plan.
Breast Cancer and its treatments
Breast Cancer Treatment Plan is totally based on several factors:
· type and stage of the cancer
· patient’s sensitivity to hormones
· age, overall health, and choices of the person
More commonly, Breast cancer has been treated with surgeries that can be either Lumpectomy or Mastectomy. The process of choosing the surgery depends on both the diagnosis and individual preference.
Read More: NGO for Cancer Patients
Breast-conserving surgery (lumpectomy) removes cancer and a part of healthy tissue around it. This surgery can be helpful in preventing the spread of cancer. However, it is only true if the tumor is small in size and can be easily separated from its surrounding tissue.
Mastectomy is surgery to remove the breast completely. However, a simple mastectomy involves removing the lobules, ducts, fatty tissue, nipple, areola, and some skin.
There are therapies available to treat breast cancer in order to completely get rid of it.
Radiation therapy – Meant to kill the remaining cancer cells, radiation therapy uses radiation treatment to kill them after surgery.
Chemotherapy – Surgeries, alone, cannot completely remove all cancer cells. Also, these cells are undetectable in routine modalities of diagnosis and remain dormant inside. Therefore, to remove the chances of reactivation of these deadly cells, doctors prefer using Chemotherapy.
The therapy requires the prescription of cytotoxic chemotherapy drugs to kill cancer cells.
In addition, there are two types of Chemotherapy:
The therapy that is done after the surgery, is called adjuvant chemotherapy.
Whereas, the therapy that is done before surgery to shrink the tumor and make its removal easier is called Neoadjuvant chemotherapy.
Hormone blocking therapy
Hormone-sensitive cancers are meant to treat specific hormonal treatments to block hormones produced in our bodies. This particular therapy is an option for those patients who are not suitable candidates for surgery, chemotherapy, or radiotherapy.
Few examples of hormone-blocking therapy medications may involve:
· tamoxifen
· aromatase inhibitors
· ovarian ablation or suppression
· Goserelin, a luteinizing hormone-releasing agonist drug that suppresses the ovaries
Read More: NGO for Cancer Patients in India
Symptoms – Swelling of the Face and Neck
Although, the main reason for swelling on the face and neck can be Lung Cancer. The theory suggests, when a tumor (malignancy) presses on the vein that goes from the head to the heart, it causes swelling. This symptom is also known as superior vena cava syndrome or superior vena cava obstruction. The term superior vena cava is the name of the vein that carries blood from the head and arms to the heart. What happens is that this vein passes near the upper part of the right lung, as well as near lymph nodes in the chest cavity, therefore, Cancer in the lymph nodes may interfere with the functioning of the superior vena cava, blocking the normal flow of blood.
Not only Breast Cancer can cause superior vena cava obstruction, but, lymphoma, testicular cancer, thyroid cancer, and a thymus tumor does too. Moreover, the side effect of radiation therapy to the chest cavity & other therapies can also cause the swelling on face & neck.
For Breast Cancer patients: To prevent swelling on face, you can contact Canwinn Foundation.
How to reduce breast cancer risk
However, there is no way to prevent Breast cancer, you can reduce the risk with some certain lifestyles.
1. For a female with the age of 50 or above, screening mammography (X-ray) once in a year will detect disease in an early stage. Therefore, the disease can be cured easily.
2. You should visit any health care provider monthly for the regular clinical breast examination. If you are noticing any lump, it is important to get it checked asap.
Lifestyle alteration is demanded that will further lessen the risk of breast cancer:
· Plan first birth before the age of 30
· Quit smoking
· Avoid excessive alcohol consumption
· Follow a physically active lifestyle
· Follow a healthful diet containing plenty of fresh fruit and vegetables
Above all, Canwinn Foundation is here to help you fight against Cancer. We take every step to cure your illness.
Be healthy!
0 notes
Text
Interventional Oncology Market Companies Analysis, Advancement and Precise Outlook – 2026
Interventional oncology is a branch of medical science that deals with minimally invasive medical procedures carried out under image guidance by interventional radiologists for the diagnosis, treatment, and palliation of different types of cancer. In interventional oncology procedures, different image guided techniques such as computed tomography, fluoroscopy, and ultrasound are used to diagnose and treat the specific site affected with the pain or cancer.
View Report : https://www.transparencymarketresearch.com/interventional-oncology-market.html
The interventional oncology procedure is most commonly performed with other cancer treatments such as surgery, chemotherapy, and radiation therapy. These procedures offer several advantages such as quicker recover, shorter hospital stays, minimal side effects, and more precise and accurate treatment compared to other therapeutic procedures.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) : https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60477
The global interventional oncology market is primarily driven by high prevalence and increase in incidence rates of cancer worldwide. Cancer is one of the leading causes of death globally after cardiovascular diseases. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths each year, with 70% new cancer cases expected to be reported over the next 20 years. The increasing cancer afflicted population is anticipated to be one of the key drivers of the market. According to a Centers for Disease Control and Prevention (CDC) report, in 2014, the number of cancer patients diagnosed in the U.S. reached approximately 21 million. This number is expected to reach 25.4 million by the end of 2024. Moreover, advantages of minimally invasive surgical procedures, technological advancements in interventional oncology, increased government funding for oncology procedures etc. are estimated to fuel the growth of the interventional oncology market during the forecast period.
The global interventional oncology market can be segmented based on procedure, Indication, and region. In terms of procedure, the interventional oncology market can be divided into ablation procedure, embolization procedure, and radiotherapy procedure. Embolization procedure is the most preferred across the globe due to benefits associated with the procedure, followed by the ablation procedure. Embolization is a process involving lodging of embolus within the bloodstream in order to block the blood supply to the tumor. The process involves chemical or irradiation technique for selective occlusion of blood vessels by introducing emboli. Radiotherapy is a treatment for cancer and other less common diseases such as thyroid, blood disorders, and even to restrict noncancerous cell growth. Radiotherapy is a widely used technique in interventional oncology. Radiotherapy procedure involves radiation through light or heat energy. The embolization segment is projected hold significant market share by the end of 2026 and is likely to expand at a rapid CAGR during the forecast period. In terms of indication, the global interventional oncology market can be categorized into lung cancer, renal cancer, osteosarcoma, hepatocellular carcinoma, splenomegaly, intrahepatic cholangiocarcinoma, neuroendocrine tumor, glioblastoma multiforme, metastatic colorectal cancer, and others.
REQUEST FOR COVID19 IMPACT ANALYSIS – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=60477
Geographically, the global interventional oncology market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to account for major share of the global interventional oncology market due to a large population base afflicted with chronic cancer such as hepatocellular carcinoma, lung cancer, renal cancer, and metastatic colorectal cancer. Moreover significant adoption of minimally invasive surgeries for the effective management of cancer, well-established health care infrastructure, and early adoption of technologically advanced interventional oncology products etc. are factors that are likely to fuel the growth of the interventional oncology market during the forecast period.
The interventional oncology market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period due to high prevalence of cancer in the highly populous countries of India and China, rapidly changing health care systems, various government initiatives to improve overall health care, and increased per capita health care expenditure. Moreover, increase in investments by leading global interventional oncology devices companies in the region is likely to contribute to the growth of the market in Asia Pacific during the forecast period.
More Trending Reports by Transparency Market Research – https://www.prnewswire.com/news-releases/developing-healthcare-infrastructure-in-asia-pacific-to-aid-the-growth-of-global-ambulance-services-market-transparency-market-research-301009662.html
Key players operating in the global interventional oncology market includes Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BTG plc, AngioDynamics, Inc., Ethicon, Inc. (Johnson & Johnson), Merit Medical Systems, Inc., Sirtex Medical Limited, Siemens Healthineers, Eckert & Ziegler BEBIG, Varian Medical Systems, Inc., and HealthTronics, Inc.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem-solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact Us
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com
0 notes
Text
Thyroid Cancer Drugs Market 2020 Growth Trends, Sales Outlook, Revenue, End-Users, Major Regions
The Business Research Company published its Thyroid Cancer Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global thyroid cancer drugs market. The report covers the thyroid cancer drugs market’s segments- Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, hospitals, oncology clinics, research organizations, radioiodine ablation, thyroid stimulating hormone (THS) suppression, chemotherapy, targeted multikinase therapy, and others.
View Complete Report: https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report
Thyroid Cancer Drugs Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Combination drugs are increasingly being used in the treatment of thyroid cancer as they are more effective and help prevent cancer progression. A combination drug includes two or more active pharmaceutical ingredients (APIs) combined in a single dosage form. These drugs reduce the development of drug resistance and prevent the growth of cancer cells.
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2601&type=smp
Few Points From Table Of Content
1. Executive Summary
2. Thyroid Cancer Drugs Market Characteristics
3. Thyroid Cancer Drugs Market Size And Growth
4. Thyroid Cancer Drugs Market Segmentation
5. Thyroid Cancer Drugs Market Regional And Country Analysis
……
25. Thyroid Cancer Drugs Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Global Thyroid Cancer Drugs Market
27. Thyroid Cancer Drugs Market Trends And Strategies
28. Thyroid Cancer Drugs Market Future Outlook and Potential Analysis
29. Appendix
Few Points From List Of Table
Table 1: Global Historic Market Growth, 2014-2018, $ Billion
Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
Table 3: Global Thyroid Cancer Drugs Market, Segmentation By Drug Type:, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
……..
Table 67: Bristol Myers co. Financial Performance
Table 68: Teva parenteral medicines Inc. Financial Performance
Table 69: Jerome Stevens Pharmaceuticals Inc. Financial Performance
Purchase A Report At: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2601
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
https://www.thebusinessresearchcompany.com
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on Blog: http://blog.tbrc.info/
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
0 notes
Text
Lalbagh Nursing Home & IVF Centre | Dr. Vidyamani Lingegowda | Elawoman
Lalbagh Nursing Home & IVF Centre
Lalbagh Nursing Home and IVF Centre is one of the leading infertility hospitals in Bangalore. Located at Sagar Chandramma Hospital No: 1, Vani Vilas Road, Metro Pillar 123 Basavanagudi Near Vasavi Choultry, Bangalore. The center was established to care for women’s unique needs in a warm, courteous and high-quality environment. It is dedicated to providing the best health-care needs to women from childbirth to adolescence and menopause.
The hospital has several fully-equipped units like Normal Delivery, Labour Epidural - Painless Labour, Cesarean Section, Family Planning Services, ART, High-Risk Pregnancy Care, Abdominal Cerclage, Electronic Fetal Monitoring, Ultrasound Scanning, and Antenatal Classes. Some of the major services provided at the center include IVF, IUI, PCOD treatment and Pregnancy Care. The IVF laboratory is equipped with modern equipment to provide safe embryo culture conditions during the treatment to achieve the highest possible clinical results. This hospital has a team of specialized and skilled medical staff to provide successful treatment to patients. The proficiency, commitment, precision, and sympathy offered at the center guarantees that the patient’s needs and expectations are met.
The patients are assisted and treated by the best medical team available in Bangalore, including Dr. Vidyamani Lingegowda, who is one of the top Infertility Specialists in Bangalore. She is the pioneer of Endometrial Ablation and Hysteroscopy in India, She started working at Lalbagh Nursing Home in 1991 and since then she has built a reputation for personalized IVF Treatment. If you know more about Best IVF Clinic so you can click here below links.
Dr. Vidyamani Lingegowda
Dr. Vidyamani Lingegowda is an Infertility Specialist who finished her MBBS from Kilpauk Medical College, 1972, DNB in Obstetrics and Gynecology and FRCOG from Royal College of Obstetricians and Gynecologists in London.
Dr. Vidyamani Lingegowda specializes in IVF, IUI, Normal vaginal delivery and High-risk pregnancy care. She is presently practicing at Lalbagh Nursing Home and IVF Centre, Jayanagar, Bangalore.
Mathrutva Fertility Center
At the point when the best of specialized specialists meet up to bring would like to the numerous families, the result is just honorable. This is the thing that Mathrutva is about – a center where life is brought into the world with most extreme consideration. Our capacity to comprehend our patients, address their issues, give them the delight of being a family, and caring about their stresses in a world-class setup is the thing that separates us. Dear parent-to-be, make proper acquaintance with our issue of free methodology.
As somebody wanting to begin your family, you will work intimately with your Mathrutva specialists and authorities. When you have mapped out a technique and an infertility treatment plan that accommodates your objectives, your calendar, and your qualities, the treatment is good to go. You will be appointed a doctor who will go the additional mile to keep a nearby watch on your own treatment plan. At Mathrutva, we understand how therapeutically and sincerely tormenting infertility is. The dread of not being ready to have an organic kid, going through invasive methods for its treatment, and the weight of the impending financial bearing, turned into an issue. Be that as it may, with our innovative and high-contact care, patients would now be able to be calm. As your fertility care pro, we invite you to end up mindful. We ask you to effectively take part in simultaneously with the goal that we can together do what's best for your future family.
Nisa Multispeciality Clinic
Nisa Multispeciality is a Fertility and Gynecology Clinic located at BTM Layout, 2nd Stage, Bangalore and was set-up in 2013. The clinic provides Physician and Gynecological services. This clinic is known for its proficient group of Medical Staff and Specialists.
This clinic provides a wide range of services like Thyroid Disorders, Hypertension treatments, General Medical Consultation, Breast Examination, Infertility Treatment, Anemia Cure, Tuberculosis Treatment, Adult Diabetes and Family Planning Advice. Nisa Multispeciality Clinics is visited by renowned Gynecologist, Dr. Uzma Zeenath Taher. Dr. Tahir Hussain Assadi who is a famous Physician also gives this clinic a visit.
Janani Clinic
Janani Clinic is a Gynecology and Women Clinic situated at JP Nagar 6 Phase, Bangalore. It is a specialty centre that provides comprehensive obstetrical and gynecological services with a holistic approach guided by professionalism and personalized care. The center was established in 2012 with the mission to provide the highest standard of complete fertility and maternity services. The center Is equipped to render a wide range of services including Cervical Cerclage, Intrauterine Insemination(IUI), Mirena (Hormonal Iud), Quad Screen, Caesarean Section(C Section), Hysterectomy (Abdominal/Vaginal), Unilateral Salpingo-Oophorectomy, D&C (Dilation and Curettage), Tubectomy/Tubal Ligation, Laparoscopic Surgery, Cervical cancer screening etc. The centre also provides routine Gynecology and Obstetric Consultation services, High-Risk Pregnancy care and Antenatal Care. The centre aims to provide world-class services to its patients under a roof.
The rooms are also spacious and well-furnished for the comfort of patients. From years of experience, learning, and research, the hospital has developed very effective management strategies for diagnosis and treatment to various ailments. The hospital also keeps updating its treatment methods according to the advancements in the field of gynecology. The hospital meets all the industry laid parameters and follows the most effective methods of treatments. The Gynecology and Obstetrics unit is led by Dr. Radha Rao, who is one of the most recommended gynecologists in South Bangalore. With more than 17 years of rich experience in treating women with all kinds of gynecological problems and high-risk pregnancies, Dr. Radha Rao strives to help women of all ages cope with the changes in their bodies while ensuring their safety, comfort, and care.
Khokar Advanced Ayurveda Center
Khokar Advanced Ayurveda Center is a Sexology Center in Bangalore. The services provided by the center are Erectile Dysfunction, Premature Ejaculation, Male Fertility Treatment, Penile Enhancement, Sexual Problems Care and Sexual Weakness Care. The commute to this clinic is a rather convenient one as various modes of conveyance are easily available. Khokar Advanced Ayurveda Center in Sastri Road has been a highly significant point of contact offering specialized services in the field of sexology. This doctor is well-versed with different aspects of human sexuality that include sexual orientation, sexual dysfunctions, and disorders, dynamics of sexual relationships, normal sexual development, etc. This medical practitioner has earned a huge reputation over the period and has become one of the most trusted medical persons in the city. Inhabitants have been seeking treatment of this specialized doctor and a large number of them have offered an overwhelming review based on their positive treatment experience.
For more information, Call Us : +91 – 8929020600
Visit Website : www.elawoman.com
Contact Form : https://www.elawoman.com/contact
Ela Facebook Ela Twitter Ela Instagram Ela Linkedin Ela Youtube
0 notes
Text
Interventional Oncology Market Report Explored in Latest Research 2018 - 2026
Interventional oncology is a branch of medical science that deals with minimally invasive medical procedures carried out under image guidance by interventional radiologists for the diagnosis, treatment, and palliation of different types of cancer. In interventional oncology procedures, different image guided techniques such as computed tomography, fluoroscopy, and ultrasound are used to diagnose and treat the specific site affected with the pain or cancer. The interventional oncology procedure is most commonly performed with other cancer treatments such as surgery, chemotherapy, and radiation therapy. These procedures offer several advantages such as quicker recover, shorter hospital stays, minimal side effects, and more precise and accurate treatment compared to other therapeutic procedures.
View Report-
https://www.transparencymarketresearch.com/interventional-oncology-market.html
The global interventional oncology market is primarily driven by high prevalence and increase in incidence rates of cancer worldwide. Cancer is one of the leading causes of death globally after cardiovascular diseases. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths each year, with 70% new cancer cases expected to be reported over the next 20 years. The increasing cancer afflicted population is anticipated to be one of the key drivers of the market. According to a Centers for Disease Control and Prevention (CDC) report, in 2014, the number of cancer patients diagnosed in the U.S. reached approximately 21 million. This number is expected to reach 25.4 million by the end of 2024. Moreover, advantages of minimally invasive surgical procedures, technological advancements in interventional oncology, increased government funding for oncology procedures etc. are estimated to fuel the growth of the interventional oncology market during the forecast period.
The global interventional oncology market can be segmented based on procedure, Indication, and region. In terms of procedure, the interventional oncology market can be divided into ablation procedure, embolization procedure, and radiotherapy procedure. Embolization procedure is the most preferred across the globe due to benefits associated with the procedure, followed by the ablation procedure. Embolization is a process involving lodging of embolus within the bloodstream in order to block the blood supply to the tumor. The process involves chemical or irradiation technique for selective occlusion of blood vessels by introducing emboli. Radiotherapy is a treatment for cancer and other less common diseases such as thyroid, blood disorders, and even to restrict noncancerous cell growth. Radiotherapy is a widely used technique in interventional oncology. Radiotherapy procedure involves radiation through light or heat energy.
The embolization segment is projected hold significant market share by the end of 2026 and is likely to expand at a rapid CAGR during the forecast period. In terms of indication, the global interventional oncology market can be categorized into lung cancer, renal cancer, osteosarcoma, hepatocellular carcinoma, splenomegaly, intrahepatic cholangiocarcinoma, neuroendocrine tumor, glioblastoma multiforme, metastatic colorectal cancer, and others.
Request Brochure-
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60477
Geographically, the global interventional oncology market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to account for major share of the global interventional oncology market due to a large population base afflicted with chronic cancer such as hepatocellular carcinoma, lung cancer, renal cancer, and metastatic colorectal cancer. Moreover significant adoption of minimally invasive surgeries for the effective management of cancer, well-established health care infrastructure, and early adoption of technologically advanced interventional oncology products etc. are factors that are likely to fuel the growth of the interventional oncology market during the forecast period.
The interventional oncology market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period due to high prevalence of cancer in the highly populous countries of India and China, rapidly changing health care systems, various government initiatives to improve overall health care, and increased per capita health care expenditure. Moreover, increase in investments by leading global interventional oncology devices companies in the region is likely to contribute to the growth of the market in Asia Pacific during the forecast period.
Request for TOC containing Tables and Figures:
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=60477
Key players operating in the global interventional oncology market includes Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BTG plc, AngioDynamics, Inc., Ethicon, Inc. (Johnson & Johnson), Merit Medical Systems, Inc., Sirtex Medical Limited, Siemens Healthineers, Eckert & Ziegler BEBIG, Varian Medical Systems, Inc., and HealthTronics, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
0 notes
Text
Hyperhidrosis Treatment Market Size, Application Analysis, Regional Outlook, 2017-2025
Hyperhidrosis, a disorder characterized by excessive sweating, can be focal or generalized. The severity of hyperhidrosis can vary from slight wetness to severe wet and can cause significant damage to the quality of life, which includes limitations in social and work relationships, leisure, and physical activities. It can even impact mental and emotional health. Hyperhidrosis can occur due to medical conditions such as diabetes, injury, such as head trauma caused by an accident, menopause, obesity, and overactive thyroid (hyperthyroidism). It affects multiple body parts, most frequently the armpits, palms, face or soles. Nearly 3% of the population, mostly individuals aged between 25 and 64 years, suffer from hyperhidrosis. Hyperhidrosis brings a significant social and psychological burden, as it hampers daily activities. However, individuals suffering from this disorder rarely seek medical help, as several patients are unaware that they are suffering from a treatable medical disorder. Primary recognition and managing of hyperhidrosis can significantly recover a patient’s quality of life. There are several systemic, topical, surgical and nonsurgical treatments available with effectiveness rates ranging between 90% and 95%.
Read Report Overview - https://www.transparencymarketresearch.com/hyperhidrosis-treatment-market.html
The global market of hyperhidrosis can be segmented based on type, treatment, end user, and geography. Based on type, the hyperhidrosis market can be classified into generalized and focal. Generalized hyperhidrosis includes the complete body and is generally a part of the primary condition, most often an endocrine, infectious, or neurologic disorder. Focal hyperhidrosis is idiopathic, arising in healthy people. Based on treatment, the hyperhidrosis market can be segregated into topical treatments, Iontophoresis, Botulinum toxin A, surgical treatments, and systemic treatments. Topical treatment includes aluminum salts, which is the most common over-the-counter ingredient in antiperspirants that are utilized to treat focal hyperhidrosis. Moreover, aldehyde agents such as glutaraldehyde and formaldehyde are also employed to treat hyperhidrosis as topical treatments. Iontophoresis is the diffusion of ions into the skin by means of an electrical current. Botulinum toxin A is used to treat hyperhidrosis, which is a form of neurotoxin produced by the anaerobic bacterium Clostridium botulinum. Surgical treatments comprise endoscopic thoracic sympathectomy that terminates the sympathetic ganglia by clamping, excision, ablation, or transection with laser or cautery. The systemic treatment includes anticholinergic agents that inhibit synaptic acetylcholine, they interfere with neuroglandular signaling. Based on distribution channel, the global market for hyperhidrosis can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
Request to View Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39308
In terms of geography, the hyperhidrosis market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Furthermore, the North America hyperhidrosis market can be segmented into U.S., and Canada. The Europe hyperhidrosis market can be segregated into U.K., Germany, France, Italy, Spain, and Rest of Europe. The Asia Pacific Hyperhidrosis market can be further segmented into Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific. The Latin America hyperhidrosis market can be segmented into Mexico, Brazil, and Rest of Latin America. Where Middle East and Africa hyperhidrosis market is segmented into Saudi Arabia, South Africa, Israel, and Rest of Middle East and Africa. North America dominates the global hyperhidrosis market, followed by Europe. The prime factors that can be attributed to the expansion of the market in these regions are rising awareness about hyperhidrosis among the adult population and availability of sophisticated and technologically advanced treatment options. According to statistics published by International Hyperhidrosis Society, The U.S. has a prominent number of hyperhidrosis cases among the major developed countries. The stated prevalence rate for hyperhidrosis in the U.S. is about 4.8%. Hyperhidrosis affects nearly 15 million people in the U.S., and approximately 5% of the global population.
Key players operating in the global hyperhidrosis market include Allergan, Miramar Labs, Inc., Brickell Biotech, Inc., Dermira, Inc., Revance Therapeutics, Inc., GlaxoSmithKline plc, and TheraVida.
Request to View ToC of the report - https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39308
0 notes
Text
Hyperhidrosis Treatment Market Foreseen to Grow Exponentially by 2025
Hyperhidrosis, a disorder characterized by excessive sweating, can be focal or generalized. The severity of hyperhidrosis can vary from slight wetness to severe wet and can cause significant damage to the quality of life, which includes limitations in social and work relationships, leisure, and physical activities. It can even impact mental and emotional health. Hyperhidrosis can occur due to medical conditions such as diabetes, injury, such as head trauma caused by an accident, menopause, obesity, and overactive thyroid (hyperthyroidism).
It affects multiple body parts, most frequently the armpits, palms, face or soles. Nearly 3% of the population, mostly individuals aged between 25 and 64 years, suffer from hyperhidrosis. Hyperhidrosis brings a significant social and psychological burden, as it hampers daily activities. However, individuals suffering from this disorder rarely seek medical help, as several patients are unaware that they are suffering from a treatable medical disorder. Primary recognition and managing of hyperhidrosis can significantly recover a patient’s quality of life. There are several systemic, topical, surgical and nonsurgical treatments available with effectiveness rates ranging between 90% and 95%.
The global Hyperhidrosis Treatment Market can be segmented based on type, treatment, end user, and geography. Based on type, the hyperhidrosis market can be classified into generalized and focal. Generalized hyperhidrosis includes the complete body and is generally a part of the primary condition, most often an endocrine, infectious, or neurologic disorder. Focal hyperhidrosis is idiopathic, arising in healthy people. Based on treatment, the hyperhidrosis market can be segregated into topical treatments, Iontophoresis, Botulinum toxin A, surgical treatments, and systemic treatments. Topical treatment includes aluminum salts, which is the most common over-the-counter ingredient in antiperspirants that are utilized to treat focal hyperhidrosis.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39308
Moreover, aldehyde agents such as glutaraldehyde and formaldehyde are also employed to treat hyperhidrosis as topical treatments. Iontophoresis is the diffusion of ions into the skin by means of an electrical current. Botulinum toxin A is used to treat hyperhidrosis, which is a form of neurotoxin produced by the anaerobic bacterium Clostridium botulinum. Surgical treatments comprise endoscopic thoracic sympathectomy that terminates the sympathetic ganglia by clamping, excision, ablation, or transection with laser or cautery. The systemic treatment includes anticholinergic agents that inhibit synaptic acetylcholine, they interfere with neuroglandular signaling. Based on distribution channel, the global market for hyperhidrosis can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
In terms of geography, the hyperhidrosis market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Furthermore, the North America hyperhidrosis market can be segmented into U.S., and Canada. The Europe hyperhidrosis market can be segregated into U.K., Germany, France, Italy, Spain, and Rest of Europe. The Asia Pacific Hyperhidrosis market can be further segmented into Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific.
The Latin America hyperhidrosis market can be segmented into Mexico, Brazil, and Rest of Latin America. Where Middle East and Africa hyperhidrosis market is segmented into Saudi Arabia, South Africa, Israel, and Rest of Middle East and Africa. North America dominates the global hyperhidrosis market, followed by Europe. The prime factors that can be attributed to the expansion of the market in these regions are rising awareness about hyperhidrosis among the adult population and availability of sophisticated and technologically advanced treatment options. According to statistics published by International Hyperhidrosis Society, The U.S. has a prominent number of hyperhidrosis cases among the major developed countries. The stated prevalence rate for hyperhidrosis in the U.S. is about 4.8%. Hyperhidrosis affects nearly 15 million people in the U.S., and approximately 5% of the global population.
Request to View ToC of the report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39308
Key players operating in the global hyperhidrosis market include Allergan, Miramar Labs, Inc., Brickell Biotech, Inc., Dermira, Inc., Revance Therapeutics, Inc., GlaxoSmithKline plc, and TheraVida.
0 notes
Text
Forecast and Analysis on Hyperhidrosis Treatment Market for Period 2017 - 2025
Hyperhidrosis, a disorder characterized by excessive sweating, can be focal or generalized. The severity of hyperhidrosis can vary from slight wetness to severe wet and can cause significant damage to the quality of life, which includes limitations in social and work relationships, leisure, and physical activities. It can even impact mental and emotional health. Hyperhidrosis can occur due to medical conditions such as diabetes, injury, such as head trauma caused by an accident, menopause, obesity, and overactive thyroid (hyperthyroidism). It affects multiple body parts, most frequently the armpits, palms, face or soles. Nearly 3% of the population, mostly individuals aged between 25 and 64 years, suffer from hyperhidrosis. Hyperhidrosis brings a significant social and psychological burden, as it hampers daily activities. However, individuals suffering from this disorder rarely seek medical help, as several patients are unaware that they are suffering from a treatable medical disorder. Primary recognition and managing of hyperhidrosis can significantly recover a patient’s quality of life. There are several systemic, topical, surgical and nonsurgical treatments available with effectiveness rates ranging between 90% and 95%.
Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/hyperhidrosis-treatment-market.html
The global market of hyperhidrosis can be segmented based on type, treatment, end user, and geography. Based on type, the hyperhidrosis market can be classified into generalized and focal. Generalized hyperhidrosis includes the complete body and is generally a part of the primary condition, most often an endocrine, infectious, or neurologic disorder. Focal hyperhidrosis is idiopathic, arising in healthy people. Based on treatment, the hyperhidrosis market can be segregated into topical treatments, Iontophoresis, Botulinum toxin A, surgical treatments, and systemic treatments. Topical treatment includes aluminum salts, which is the most common over-the-counter ingredient in antiperspirants that are utilized to treat focal hyperhidrosis. Moreover, aldehyde agents such as glutaraldehyde and formaldehyde are also employed to treat hyperhidrosis as topical treatments. Iontophoresis is the diffusion of ions into the skin by means of an electrical current. Botulinum toxin A is used to treat hyperhidrosis, which is a form of neurotoxin produced by the anaerobic bacterium Clostridium botulinum. Surgical treatments comprise endoscopic thoracic sympathectomy that terminates the sympathetic ganglia by clamping, excision, ablation, or transection with laser or cautery. The systemic treatment includes anticholinergic agents that inhibit synaptic acetylcholine, they interfere with neuroglandular signaling. Based on distribution channel, the global market for hyperhidrosis can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39308
In terms of geography, the hyperhidrosis market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Furthermore, the North America hyperhidrosis market can be segmented into U.S., and Canada. The Europe hyperhidrosis market can be segregated into U.K., Germany, France, Italy, Spain, and Rest of Europe. The Asia Pacific Hyperhidrosis market can be further segmented into Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific. The Latin America hyperhidrosis market can be segmented into Mexico, Brazil, and Rest of Latin America. Where Middle East and Africa hyperhidrosis market is segmented into Saudi Arabia, South Africa, Israel, and Rest of Middle East and Africa. North America dominates the global hyperhidrosis market, followed by Europe. The prime factors that can be attributed to the expansion of the market in these regions are rising awareness about hyperhidrosis among the adult population and availability of sophisticated and technologically advanced treatment options. According to statistics published by International Hyperhidrosis Society, The U.S. has a prominent number of hyperhidrosis cases among the major developed countries. The stated prevalence rate for hyperhidrosis in the U.S. is about 4.8%. Hyperhidrosis affects nearly 15 million people in the U.S., and approximately 5% of the global population.
Key players operating in the global hyperhidrosis market include Allergan, Miramar Labs, Inc., Brickell Biotech, Inc., Dermira, Inc., Revance Therapeutics, Inc., GlaxoSmithKline plc, and TheraVida.
Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=39308
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Contact US:
Transparency Market Research,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: [email protected]
Website: https://www.transparencymarketresearch.com
0 notes
Text
Know what your irregular heartbeat could mean…
An irregular heartbeat is when your heart beats too fast, too slow or with an irregular pattern.
This irregular pattern of a heartbeat is known as Arrhythmia. Premature or extra beats are the most common Arrhythmia Types. Abnormal Heartbeat Symptoms feels like a fluttering in the chest or a feeling of a skipped heartbeat. The Heart has an electrical system that instructs it when to beat and push blood around the body. If there is a trouble with this Normal Heartbeat
System the person might experience heart rhythm disorders.
Some of the heart rhythm disorder causes are mentioned below:
● Heart failure & heart attack
● Congenital heart defects
● High blood pressure
● Infections that damage the heart muscle or the sac around the heart
● Diabetes
● Acute sleep disorders
● An overactive or under-active thyroid gland
● There are different arrhythmia types out of which the most common is Atrial fibrillation which arises when the normal beating in the upper chambers of the heart is irregular, and blood doesn’t flow properly the way it should from the atria (upper chambers) to the lower chambers of the heart.
Fast heart patterns such as supra ventricular tachycardia (SVT), inappropriate sinus tachycardia, atrial flutter, atrial fibrillation (AF), ventricular tachycardia (VT) and ventricular fibrillation (VF) are called as tachycardia. Whereas, slow heart patterns such as AV heart block, bundle branch block and tachy brady syndrome are called brady cardias.
Some of the abnormal heartbeat symptoms are:
● Fatigue
● Dizziness
● Light-headedness
● fainting
● Rapid heartbeat or pounding
● Anxiety
● Shortness of breath
● sweating
● chest pain
● collapse and cardiac arrest (in extreme cases)
Arrhythmia diagnosis involves a detailed interview which includes the patient’s medical history,
family history, diet, and lifestyle. This includes few tests such as:
● Blood and Urine tests – to check the patient’s blood count and liver, thyroid, and kidney function and also to check for electrolytes and other chemicals.
● ECG (Electrocardiogram) – to record and check How Heart Functions and the electrical activity and rhythm of the patient’s heart.
● Holter monitor – to record the patient’s heart for one or two days. When symptoms are seen a button can be pressed which allows the doctor to see what heart rhythms were present at that moment.
● Echocardiogram – This is an ultrasound scan that checks the pumping action of the Patient’s heart.
● Chest X-Ray - the images help the doctor check the state of the patient’s heart and the lungs.
● Tilt-Table test - This test is recommended if the patient experiences fainting, dizziness or lightheadedness, and if the ECG and the Holter fails to diagnose any arrhythmias.
● Electrophysiological testing (EP study) – EP study procedure records the electrical system of the heart and helps to determine the type of arrhythmia, why it is happening and how it might respond to treatment.
● Heart Catheterization – This test provides information on how well the heart is working.
A thin, hollow tube called a catheter is inserted into a large blood vessel, usually in the groin.
Arrhythmia diagnosis and treatment is very necessary and needs to be attended with higher priority if it is serious. Some of the common treatments are:
● Electrical ‘shock’ therapy (defibrillation or cardio version)
● Implanting a short-term heart pacemaker.
● Medications given through a vein (intravenous) or by mouth.
● Medications called anti-arrhythmic drugs may be used to prevent an arrhythmia from happening again.
● Cardiac ablation is used to destroy areas in your heart that causes heart rhythm problems
● An implantable cardiac defibrillator is placed for patients who are at high risk of sudden cardiac death.
An ICD monitors the heart rhythms. If the ICD feels dangerous rhythms, it provides shocks. This treatment is called defibrillation. Most new ICDs can act both as an artificial pacemaker and a defibrillator It can help to control serious arrhythmias, especially those that can cause sudden cardiac arrest and death. Many ICDs also record the heart’s electrical patterns when there is an abnormal heartbeat which helps the doctor plan future treatment. ICDs have proven to be helpful in preventing sudden death in patients with known, sustained ventricular tachycardia or fibrillation. An artificial pacemaker is a small electrical device that is used to prevent a heart from beating abnormally. It is used to treat the abnormal heart rhythms that can cause the heart to beat too slowly or miss beats. An artificial pacemaker is a generator which is made of a battery and computer circuitry that is paced in a metal casing which is implanted under the skin in the upper chest or shoulder region. The wires of the pacemaker are threaded through the veins of the shoulder and are connected to the heart with the help of X-rays. After the wires are connected to the heart they are fixed to the generator. Some pacemakers can also help the chambers of the heartbeat in time.
Narayana Health is one of the best hospitals in India for Irregular heartbeat treatment with some of the best-skilled doctors in the country. The hospital is also a pioneer in Pacemaker implantation surgery and cardiac Resynchronisation therapy. Narayana health is the best hospital in India with 23 hospitals, 7 heart centres and a network of primary health centres across India and also 1 hospital in the Cayman Islands. Narayana health provides high quality healthcare services for Arrhythmia treatment in India with a team of best physicians who are dedicated and experienced. This super speciality hospital in India provides advanced care in and over 30 medical specialties including cardiology and cardiac surgery, cancer care, neurology and neurosurgery, orthopaedics, nephrology and urology and gastroenterology.
#Arrhythmia#Arrhythmia Types#regular heartbeat treatment#heart rhythm disorders causes#normal heartbeat#Irregular heartbeat treatment#pacemaker implantation surgery
0 notes
Last Seen Blogs
